Nrf2 pathway activation upon rotenone treatment in human iPSC-derived neural stem cells undergoing differentiation towards neurons and astrocytes

Neurochemistry International

Volumn 108, Issue , 2017, Pages 457-471

  Pistollato, Francesca ^a   Canovas Jorda, David ^a   Zagoura, Dimitra ^a   Bal Price, Anna ^a  

^a JOINT RESEARCH CENTRE   (Italy)

Author keywords

Astrocyte; Dopaminergic neurons; Neural stem cells; Neurite length; Neurotoxicity; Nrf2 pathway; Rotenone

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; BETA III TUBULIN; BETA TUBULIN; COMPLEMENTARY DNA; GLIAL FIBRILLARY ACIDIC PROTEIN; KELCH LIKE ECH ASSOCIATED PROTEIN 1; KI 67 ANTIGEN; MICROTUBULE ASSOCIATED PROTEIN 2; NAD(P)H QUINONE OXIDOREDUCTASE 1; NESTIN; NEUROMODULIN; PEPTIDES AND PROTEINS; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); ROTENONE; SULFIREDOXIN 1; SYNAPTOPHYSIN; TAU PROTEIN; TRANSCRIPTION FACTOR NRF2; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1; NFE2L2 PROTEIN, HUMAN; UNCOUPLING PROTEIN;

ACTION POTENTIAL; ARTICLE; ASTROCYTE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CULTURAL ANTHROPOLOGY; CYTOPLASM; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; ELECTRIC ACTIVITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INDUCED PLURIPOTENT STEM CELL; INTRACELLULAR SIGNALING; MIXED CELL CULTURE; MOUSE; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEURITE OUTGROWTH; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPEATED DRUG DOSE; RNA ISOLATION; STEM CELL CULTURE; STEM CELL EXPANSION; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; CELL CULTURE; CELL DIFFERENTIATION; DRUG EFFECTS; METABOLISM; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; PHYSIOLOGY;

ASTROCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; INDUCED PLURIPOTENT STEM CELLS; NEURAL STEM CELLS; NEUROGENESIS; NEURONS; NF-E2-RELATED FACTOR 2; ROTENONE; UNCOUPLING AGENTS;

EID: 85021182553     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2017.06.006     Document Type: Article

References (81)

1. Agarwal, A., Aponte-Mellado, A., Premkumar, B.J., Shaman, A., Gupta, S., The effects of oxidative stress on female reproduction: a review. Reprod. Biol. Endocrinol., 10, 2012, 49.
2. Al-Gubory, K.H., Environmental pollutants and lifestyle factors induce oxidative stress and poor prenatal development. Reprod. Biomed. Online 29 (2014), 17–31.
3. Al-Gubory, K.H., Fowler, P.A., Garrel, C., The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes. Int. J. Biochem. Cell Biol. 42 (2010), 1634–1650.
4. Aschner, M., Ceccatelli, S., Daneshian, M., Fritsche, E., Hasiwa, N., Hartung, T., Hogberg, H.T., Leist, M., Li, A., Mundi, W.R., Padilla, S., Piersma, A.H., Bal-Price, A., Seiler, A., Westerink, R.H., Zimmer, B., Lein, P.J., Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use. ALTEX 34 (2017), 49–74.
5. Avior, Y., Sagi, I., Benvenisty, N., Pluripotent stem cells in disease modelling and drug discovery. Nat. Rev. Mol. Cell Biol. 17 (2016), 170–182.
6. Bal-Price, A.K., Hogberg, H.T., Buzanska, L., Coecke, S., Relevance of in vitro neurotoxicity testing for regulatory requirements: challenges to be considered. Neurotoxicol. Teratol. 32 (2010), 36–41.
7. Bal-Price, A.K., Coecke, S., Costa, L., Crofton, K.M., Fritsche, E., Goldberg, A., Grandjean, P., Lein, P.J., Li, A., Lucchini, R., Mundy, W.R., Padilla, S., Persico, A.M., Seiler, A.E., Kreysa, J., Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation. ALTEX 29 (2012), 202–215.
8. Bal-Price, A., Crofton, K.M., Leist, M., Allen, S., Arand, M., Buetler, T., Delrue, N., FitzGerald, R.E., Hartung, T., Heinonen, T., Hogberg, H., Bennekou, S.H., Lichtensteiger, W., Oggier, D., Paparella, M., Axelstad, M., Piersma, A., Rached, E., Schilter, B., Schmuck, G., Stoppini, L., Tongiorgi, E., Tiramani, M., Monnet-Tschudi, F., Wilks, M.F., Ylikomi, T., Fritsche, E., International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes. Arch. Toxicol. 89 (2015), 269–287.
9. Bal-Price, A., Crofton, K.M., Sachana, M., Shafer, T.J., Behl, M., Forsby, A., Hargreaves, A., Landesmann, B., Lein, P.J., Louisse, J., Monnet-Tschudi, F., Paini, A., Rolaki, A., Schrattenholz, A., Sunol, C., van Thriel, C., Whelan, M., Fritsche, E., Putative adverse outcome pathways relevant to neurotoxicity. Crit. Rev. Toxicol. 45 (2015), 83–91.
10. Bal-Price, A., Leist, M., Schildknecht, S., Tschudi-Monnet, F., Paini, A., Terron, A., AOP3: inhibition of the mitochondrial complex I of nigra-striatal neurons leads to parkinsonian motor deficits. https://aopwiki.org/aops/3, 2017.
11. Bell, K.F., Al-Mubarak, B., Fowler, J.H., Baxter, P.S., Gupta, K., Tsujita, T., Chowdhry, S., Patani, R., Chandran, S., Horsburgh, K., Hayes, J.D., Hardingham, G.E., Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioning. Proc. Natl. Acad. Sci. U. S. A., 108, 2011 E1–2; author reply E3–4.
12. Bennett, D., Bellinger, D.C., Birnbaum, L.S., Bradman, A., Chen, A., Cory-Slechta, D.A., Engel, S.M., Fallin, M.D., Halladay, A., Hauser, R., Hertz-Picciotto, I., Kwiatkowski, C.F., Lanphear, B.P., Marquez, E., Marty, M., McPartland, J., Newschaffer, C.J., Payne-Sturges, D., Patisaul, H.B., Perera, F.P., Ritz, B., Sass, J., Schantz, S.L., Webster, T.F., Whyatt, R.M., Woodruff, T.J., Zoeller, R.T., Anderko, L., Campbell, C., Conry, J.A., DeNicola, N., Gould, R.M., Hirtz, D., Huffling, K., Landrigan, P.J., Lavin, A., Miller, M., Mitchell, M.A., Rubin, L., Schettler, T., Tran, H.L., Acosta, A., Brody, C., Miller, E., Miller, P., Swanson, M., Witherspoon, N.O., American College of, O., Gynecologists, Child Neurology, S., Endocrine, S., International Neurotoxicology, A., International Society for Children's, H., the, E., International Society for Environmental, E., National Council of Asian Pacific Islander, P., National Hispanic Medical, A., National Medical, A. Project TENDR: targeting environmental neuro-developmental risks the TENDR consensus statement. Environ. Health Perspect. 124 (2016), A118–A122.
13. Bolaños, J.P., Bioenergetics and redox adaptations of astrocytes to neuronal activity. J. Neurochem. 139 (2016), 115–125.
14. Borland, M.K., Trimmer, P.A., Rubinstein, J.D., Keeney, P.M., Mohanakumar, K., Liu, L., Bennett, J.P. Jr., Chronic, low-dose rotenone reproduces Lewy neurites found in early stages of Parkinson's disease, reduces mitochondrial movement and slowly kills differentiated SH-SY5Y neural cells. Mol. Neurodegener., 3, 2008, 21.
15. Breier, J.M., Gassmann, K., Kayser, R., Stegeman, H., De Groot, D., Fritsche, E., Shafer, T.J., Neural progenitor cells as models for high-throughput screens of developmental neurotoxicity: state of the science. Neurotoxicol. Teratol. 32 (2010), 4–15.
16. Bryan, H.K., Olayanju, A., Goldring, C.E., Park, B.K., The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation. Biochem. Pharmacol. 85 (2013), 705–717.
17. Cabezas, R., El-Bacha, R.S., Gonzalez, J., Barreto, G.E., Mitochondrial functions in astrocytes: neuroprotective implications from oxidative damage by rotenone. Neurosci. Res. 74 (2012), 80–90.
18. Caboni, P., Sherer, T.B., Zhang, N., Taylor, G., Na, H.M., Greenamyre, J.T., Casida, J.E., Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease. Chem. Res. Toxicol. 17 (2004), 1540–1548.
19. Calabresi, P., Gubellini, P., Picconi, B., Centonze, D., Pisani, A., Bonsi, P., Greengard, P., Hipskind, R.A., Borrelli, E., Bernardi, G., Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine. J. Neurosci. 21 (2001), 5110–5120.
20. Calkins, M.J., Vargas, M.R., Johnson, D.A., Johnson, J.A., Astrocyte-specific overexpression of Nrf2 protects striatal neurons from mitochondrial complex II inhibition. Toxicol. Sci. 115 (2010), 557–568.
21. Cannon, J.R., Tapias, V., Na, H.M., Honick, A.S., Drolet, R.E., Greenamyre, J.T., A highly reproducible rotenone model of Parkinson's disease. Neurobiol. Dis. 34 (2009), 279–290.
22. Centonze, D., Prosperetti, C., Barone, I., Rossi, S., Picconi, B., Tscherter, A., De Chiara, V., Bernardi, G., Calabresi, P., NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum. Exp. Neurol. 202 (2006), 470–479.
23. Costa, C., Belcastro, V., Tozzi, A., Di Filippo, M., Tantucci, M., Siliquini, S., Autuori, A., Picconi, B., Spillantini, M.G., Fedele, E., Pittaluga, A., Raiteri, M., Calabresi, P., Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. J. Neurosci. 28 (2008), 8040–8052.
24. Crofton, K.M., Mundy, W.R., Shafer, T.J., Developmental neurotoxicity testing: a path forward. Congenit. Anom. (Kyoto) 52 (2012), 140–146.
25. Cui, T., Lai, Y., Janicki, J.S., Wang, X., Nuclear factor erythroid-2 related factor 2 (Nrf2)-mediated protein quality control in cardiomyocytes. Front. Biosci. Landmark Ed. 21 (2016), 192–202.
26. de Oliveira, M.R., Ferreira, G.C., Schuck, P.F., Dal Bosco, S.M., Role for the PI3K/Akt/Nrf2 signaling pathway in the protective effects of carnosic acid against methylglyoxal-induced neurotoxicity in SH-SY5Y neuroblastoma cells. Chemico-Biological Interact. 242 (2015), 396–406.
27. Ferrante, R.J., Schulz, J.B., Kowall, N.W., Beal, M.F., Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra. Brain Res. 753 (1997), 157–162.
28. Fritsche, E., Crofton, K.M., Hernandez, A.F., Hougaard Bennekou, S., Leist, M., Bal-Price, A., Reaves, E., Wilks, M.F., Terron, A., Solecki, R., Gourmelon, A., OECD/EFSA workshop on developmental neurotoxicity (DNT): the use of non-animal test methods for regulatory purposes. ALTEX 34 (2017), 311–315.
29. Fujita, K.A., Ostaszewski, M., Matsuoka, Y., Ghosh, S., Glaab, E., Trefois, C., Crespo, I., Perumal, T.M., Jurkowski, W., Antony, P.M., Diederich, N., Buttini, M., Kodama, A., Satagopam, V.P., Eifes, S., Del Sol, A., Schneider, R., Kitano, H., Balling, R., Integrating pathways of Parkinson's disease in a molecular interaction map. Mol. Neurobiol. 49 (2014), 88–102.
30. Gao, X.F., Wang, W., He, C., Rotenone inhibits delayed rectifier K+ current via a protein kinase A-dependent mechanism. Neuroreport 19 (2008), 1401–1405.
31. Gorrini, C., Harris, I.S., Mak, T.W., Modulation of oxidative stress as an anticancer strategy. Nat. Rev. Drug Discov. 12 (2013), 931–947.
32. Grandjean, P., Landrigan, P.J., Developmental neurotoxicity of industrial chemicals. Lancet 368 (2006), 2167–2178.
33. Grandjean, P., Landrigan, P.J., Neurobehavioural effects of developmental toxicity. Lancet Neurol. 13 (2014), 330–338.
34. Greene, J.G., Greenamyre, J.T., Bioenergetics and glutamate excitotoxicity. Prog. Neurobiol. 48 (1996), 613–634.
35. Guo, S.S., Cui, X.L., Rausch, W.D., Ganoderma Lucidum polysaccharides protect against MPP(+) and rotenone-induced apoptosis in primary dopaminergic cell cultures through inhibiting oxidative stress. Am. J. Neurodegener. Dis. 5 (2016), 131–144.
36. Gupta, K., Chandran, S., Hardingham, G.E., Human stem cell-derived astrocytes and their application to studying Nrf2-mediated neuroprotective pathways and therapeutics in neurodegeneration. Br. J. Clin. Pharmacol. 75 (2013), 907–918.
37. Hoglinger, G.U., Feger, J., Prigent, A., Michel, P.P., Parain, K., Champy, P., Ruberg, M., Oertel, W.H., Hirsch, E.C., Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J. Neurochem. 84 (2003), 491–502.
38. Hoglinger, G.U., Lannuzel, A., Khondiker, M.E., Michel, P.P., Duyckaerts, C., Feger, J., Champy, P., Prigent, A., Medja, F., Lombes, A., Oertel, W.H., Ruberg, M., Hirsch, E.C., The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. J. Neurochem. 95 (2005), 930–939.
39. Jiang, M., Yun, Q., Shi, F., Niu, G., Gao, Y., Xie, S., Yu, S., Downregulation of miR-384-5p attenuates rotenone-induced neurotoxicity in dopaminergic SH-SY5Y cells through inhibiting endoplasmic reticulum stress. Am. J. Physiol. Cell Physiol. 310 (2016), C755–C763.
40. Johnson, D.A., Johnson, J.A., Nrf2–a therapeutic target for the treatment of neurodegenerative diseases. Free Radic. Biol. Med. 88 (2015), 253–267.
41. Johnson, J.A., Johnson, D.A., Kraft, A.D., Calkins, M.J., Jakel, R.J., Vargas, M.R., Chen, P.C., The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann. N. Y. Acad. Sci. 1147 (2008), 61–69.
42. Karkkainen, V., Pomeshchik, Y., Savchenko, E., Dhungana, H., Kurronen, A., Lehtonen, S., Naumenko, N., Tavi, P., Levonen, A.L., Yamamoto, M., Malm, T., Magga, J., Kanninen, K.M., Koistinaho, J., Nrf2 regulates neurogenesis and protects neural progenitor cells against Abeta toxicity. Stem Cells 32 (2014), 1904–1916.
43. Kosaka, K., Mimura, J., Itoh, K., Satoh, T., Shimojo, Y., Kitajima, C., Maruyama, A., Yamamoto, M., Shirasawa, T., Role of Nrf2 and p62/ZIP in the neurite outgrowth by carnosic acid in PC12h cells. J. Biochem. 147 (2010), 73–81.
44. Kraft, A.D., Johnson, D.A., Johnson, J.A., Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J. Neurosci. 24 (2004), 1101–1112.
45. Krug, A.K., Balmer, N.V., Matt, F., Schonenberger, F., Merhof, D., Leist, M., Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants. Arch. Toxicol. 87 (2013), 2215–2231.
46. Kweon, G.R., Marks, J.D., Krencik, R., Leung, E.H., Schumacker, P.T., Hyland, K., Kang, U.J., Distinct mechanisms of neurodegeneration induced by chronic complex I inhibition in dopaminergic and non-dopaminergic cells. J. Biol. Chem. 279 (2004), 51783–51792.
47. Li, J., Spletter, M.L., Johnson, D.A., Wright, L.S., Svendsen, C.N., Johnson, J.A., Rotenone-induced caspase 9/3-independent and -dependent cell death in undifferentiated and differentiated human neural stem cells. J. Neurochem. 92 (2005), 462–476.
48. Li, L., Dong, H., Song, E., Xu, X., Liu, L., Song, Y., Nrf2/ARE pathway activation, HO-1 and NQO1 induction by polychlorinated biphenyl quinone is associated with reactive oxygen species and PI3K/AKT signaling. Chemico-Biological Interact. 209 (2014), 56–67.
49. Li, J., Zhang, Y., Luan, H., Chen, X., Han, Y., Wang, C., l-carnitine protects human hepatocytes from oxidative stress-induced toxicity through Akt-mediated activation of Nrf2 signaling pathway. Can. J. Physiol. Pharmacol. 94 (2016), 517–525.
50. Liu, C., Ye, Y., Zhou, Q., Zhang, R., Zhang, H., Liu, W., Xu, C., Liu, L., Huang, S., Chen, L., Crosstalk between Ca2+ signaling and mitochondrial H2O2 is required for rotenone inhibition of mTOR signaling pathway leading to neuronal apoptosis. Oncotarget 7 (2016), 7534–7549.
51. Liu, H., Yu, C., Xu, T., Zhang, X., Dong, M., Synergistic protective effect of paeoniflorin and beta-ecdysterone against rotenone-induced neurotoxicity in PC12 cells. Apoptosis 21 (2016), 1354–1365.
52. Luetjens, C.M., Bui, N.T., Sengpiel, B., Munstermann, G., Poppe, M., Krohn, A.J., Bauerbach, E., Krieglstein, J., Prehn, J.H., Delayed mitochondrial dysfunction in excitotoxic neuron death: cytochrome c release and a secondary increase in superoxide production. J. Neurosci. 20 (2000), 5715–5723.
53. Marey-Semper, I., Gelman, M., Levi-Strauss, M., A selective toxicity toward cultured mesencephalic dopaminergic neurons is induced by the synergistic effects of energetic metabolism impairment and NMDA receptor activation. J. Neurosci. 15 (1995), 5912–5918.
54. Michel, H.E., Tadros, M.G., Esmat, A., Khalifa, A.E., Abdel-Tawab, A.M., Tetramethylpyrazine ameliorates rotenone-induced Parkinson's disease in rats: involvement of its anti-inflammatory and anti-apoptotic actions. Mol. Neurobiol., 2016, 1–13.
55. Nataraj, J., Manivasagam, T., Justin Thenmozhi, A., Essa, M.M., Neuroprotective effect of asiatic acid on rotenone-induced mitochondrial dysfunction and oxidative stress-mediated apoptosis in differentiated SH-SYS5Y cells. Nutr. Neurosci. 20 (2017), 351–359.
56. Neri, M., Bello, S., Turillazzi, E., Riezzo, I., Drugs of abuse in pregnancy, poor neonatal development, and future neurodegeneration. Is oxidative stress the culprit?. Curr. Pharm. Des. 21 (2015), 1358–1368.
57. (NRC), N.R.C, Toxicity Testing in the 21st Century: a Vision and a Strategy. 2007, National Academy Press, Washington, DC.
58. O'Brien, P.J., Irwin, W., Diaz, D., Howard-Cofield, E., Krejsa, C.M., Slaughter, M.R., Gao, B., Kaludercic, N., Angeline, A., Bernardi, P., Brain, P., Hougham, C., High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch. Toxicol. 80 (2006), 580–604.
59. Pei, Y., Peng, J., Behl, M., Sipes, N.S., Shockley, K.R., Rao, M.S., Tice, R.R., Zeng, X., Comparative neurotoxicity screening in human iPSC-derived neural stem cells, neurons and astrocytes. Brain Res. 1638 (2016), 57–73.
60. Pistollato, F., Louisse, J., Scelfo, B., Mennecozzi, M., Accordi, B., Basso, G., Gaspar, J.A., Zagoura, D., Barilari, M., Palosaari, T., Sachinidis, A., Bremer-Hoffmann, S., Development of a pluripotent stem cell derived neuronal model to identify chemically induced pathway perturbations in relation to neurotoxicity: effects of CREB pathway inhibition. Toxicol. Appl. Pharmacol. 280 (2014), 378–388.
61. Radio, N.M., Neurite outgrowth assessment using high content analysis methodology. Methods Mol. Biol. 846 (2012), 247–260.
62. Ramsey, C.P., Glass, C.A., Montgomery, M.B., Lindl, K.A., Ritson, G.P., Chia, L.A., Hamilton, R.L., Chu, C.T., Jordan-Sciutto, K.L., Expression of Nrf2 in neurodegenerative diseases. J. Neuropathol. Exp. Neurol. 66 (2007), 75–85.
63. Robinton, D.A., Daley, G.Q., The promise of induced pluripotent stem cells in research and therapy. Nature 481 (2012), 295–305.
64. Ryan, K.R., Sirenko, O., Parham, F., Hsieh, J.H., Cromwell, E.F., Tice, R.R., Behl, M., Neurite outgrowth in human induced pluripotent stem cell-derived neurons as a high-throughput screen for developmental neurotoxicity or neurotoxicity. Neurotoxicology 53 (2016), 271–281.
65. Sherer, T.B., Kim, J.H., Betarbet, R., Greenamyre, J.T., Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp. Neurol. 179 (2003), 9–16.
66. Singh, S., Srivastava, A., Kumar, V., Pandey, A., Kumar, D., Rajpurohit, C.S., Khanna, V.K., Yadav, S., Pant, A.B., Stem cells in neurotoxicology/developmental neurotoxicology: current scenario and future prospects. Mol. Neurobiol. 53 (2016), 6938–6949.
67. Steele, M.L., Fuller, S., Patel, M., Kersaitis, C., Ooi, L., Munch, G., Effect of Nrf2 activators on release of glutathione, cysteinylglycine and homocysteine by human U373 astroglial cells. Redox Biol. 1 (2013), 441–445.
68. Sun, Z., Zhang, S., Chan, J.Y., Zhang, D.D., Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2. Mol. Cell Biol. 27 (2007), 6334–6349.
69. Swarnkar, S., Singh, S., Goswami, P., Mathur, R., Patro, I.K., Nath, C., Astrocyte activation: a key step in rotenone induced cytotoxicity and DNA damage. Neurochem. Res. 37 (2012), 2178–2189.
70. Tanner, C.M., Kamel, F., Ross, G.W., Hoppin, J.A., Goldman, S.M., Korell, M., Marras, C., Bhudhikanok, G.S., Kasten, M., Chade, A.R., Comyns, K., Richards, M.B., Meng, C., Priestley, B., Fernandez, H.H., Cambi, F., Umbach, D.M., Blair, A., Sandler, D.P., Langston, J.W., Rotenone, paraquat, and Parkinson's disease. Environ. Health Perspect. 119 (2011), 866–872.
71. Tantucci, M., Mariucci, G., Taha, E., Spaccatini, C., Tozzi, A., Luchetti, E., Calabresi, P., Ambrosini, M.V., Induction of heat shock protein 70 reduces the alteration of striatal electrical activity caused by mitochondrial impairment. Neuroscience 163 (2009), 735–740.
72. Testa, C.M., Sherer, T.B., Greenamyre, J.T., Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures. Brain research. Mol. Brain Res. 134 (2005), 109–118.
73. Tufekci, K.U., Civi Bayin, E., Genc, S., Genc, K., The nrf2/ARE pathway: a promising target to counteract mitochondrial dysfunction in Parkinson's disease. Parkinson's Dis., 2011, 2011, 314082.
74. Uchi, H., Yasumatsu, M., Morino-Koga, S., Mitoma, C., Furue, M., Inhibition of aryl hydrocarbon receptor signaling and induction of NRF2-mediated antioxidant activity by cinnamaldehyde in human keratinocytes. J. Dermatol Sci. 85 (2017), 36–43.
75. Xia, B., Liu, H., Xie, J., Wu, R., Li, Y., Akt enhances nerve growth factor-induced axon growth via activating the Nrf2/ARE pathway. Int. J. Mol. Med. 36 (2015), 1426–1432.
76. Xiong, N., Long, X., Xiong, J., Jia, M., Chen, C., Huang, J., Ghoorah, D., Kong, X., Lin, Z., Wang, T., Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models. Crit. Rev. Toxicol. 42 (2012), 613–632.
77. Yang, C., Cheng, Y., Zhao, J., Rong, J., Releasing Nrf2 to promote neurite outgrowth. Neural Regen. Res. 10 (2015), 1934–1935.
78. Yang, Y., Jiang, S., Yan, J., Li, Y., Xin, Z., Lin, Y., Qu, Y., An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders. Cytokine Growth Factor Rev. 26 (2015), 47–57.
79. Zagoura, D., Canovas-Jorda, D., Pistollato, F., Bremer-Hoffmann, S., Bal-Price, A., Evaluation of the rotenone-induced activation of the Nrf2 pathway in a neuronal model derived from human induced pluripotent stem cells. Neurochem. Int. 106 (2017), 62–73.
80. Zhao, F., Wu, T., Lau, A., Jiang, T., Huang, Z., Wang, X.J., Chen, W., Wong, P.K., Zhang, D.D., Nrf2 promotes neuronal cell differentiation. Free Radic. Biol. Med. 47 (2009), 867–879.
81. Zhou, Y., Duan, S., Zhou, Y., Yu, S., Wu, J., Wu, X., Zhao, J., Zhao, Y., Sulfiredoxin-1 attenuates oxidative stress via Nrf2/ARE pathway and 2-Cys Prdxs after oxygen-glucose deprivation in astrocytes. J. Mol. Neurosci. 55 (2015), 941–950.